|
Nov 15
|
We're Keeping An Eye On Longeveron's (NASDAQ:LGVN) Cash Burn Rate
|
|
Nov 13
|
LGVN Highlights Potential Groundbreaking Treatments
|
|
Nov 12
|
Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update
|
|
Nov 11
|
Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC)
|
|
Oct 9
|
Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting
|
|
Oct 7
|
Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day
|
|
Oct 2
|
Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
|
|
Sep 26
|
Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
|
|
Aug 26
|
Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
|
Jul 29
|
Why Is Alzheimer's-Focused Longeveron Stock Trading Higher On Monday?
|
|
Jul 29
|
Longeveron’s Phase IIa Alzheimer’s therapy trial meets efficacy endpoints
|
|
Jul 28
|
Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)
|
|
Jul 27
|
Bullish Longeveron Insiders Loaded Up On US$734.3k Of Stock
|
|
Jun 21
|
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
|
|
Jun 12
|
LGVN Provides Encouraging Update and Improved Revenue
|
|
Jun 12
|
Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
|
|
Jun 11
|
Longeveron® Announces Completion of Successful Investigator Meeting for On-going Phase 2b Clinical Trial Evaluating Lomecel-B™ as a Potential Treatment for HLHS, a Rare Pediatric Cardiac Disease
|
|
Jun 11
|
Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now
|
|
Jun 10
|
Longeveron to Present at the Emerging Growth Virtual Conference on June 12, 2024
|
|
May 15
|
LGVN Making Great Strides
|